Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
To get it in your inbox, subscribe here
Like any medication, GLP-1 RA drugs can have side effects, especially in the gastrointestinal tract
Stopping GLP-1 drugs can quickly erase cardiovascular benefits Even brief interruption tied to change in risk of heart attack, stroke and death Sara Moser and Alaska Adams / WashU Medicine Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S
Increasing the dose slowly over time helps to minimize the frequency and severity of GI symptoms
In our new study, we set out to address this question using a combination of animal models, immunophenotyping, transcriptomics, and proteomics
